Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of gastrointestinal lipid digestion on intraluminal behavior of abiraterone acetate
2019-003460-50Phase 4Completed
- Sponsor
- KU Leuven Drug Delivery and Disposition
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of abiraterone (3 arms), sponsored by KU Leuven Drug Delivery and Disposition. Primary endpoint: Intraluminal behavior of abiraterone acetate along the intestinal tract. Started Sep 2019; status: completed.
02
Drugs
abiraterone
Beyond the preview
Go deeper on 2019-003460-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003460-50.